Treatment Arm
Visit number vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline Visit | 163 | 46.8 | ± 11.5 | 52.0 | 13.1 | 55.9 | 6 | 169 |
Month-6 Follow-up Visit | 138 | 48.7 | ± 10.0 | 55.9 | 13.1 | 55.9 | 31 | 169 |
Month-12 Follow-up Visit | 77 | 48.4 | ± 11.2 | 55.9 | 13.1 | 55.9 | 31 | 108 |
Treatment arm vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 46.8 | ± 11.5 | 52.0 | 13.1 | 55.9 | 6 | 169 |
Conservative Medical Therapy (CMT) | 43 | 47.9 | ± 10.7 | 52.0 | 17.0 | 55.9 | 1 | 44 |
CMT + Sham CPAP | 40 | 44.9 | ± 12.3 | 50.0 | 20.9 | 55.9 | 2 | 42 |
CMT + Active CPAP | 40 | 48.7 | ± 10.8 | 53.9 | 13.1 | 55.9 | 2 | 42 |
CMT + Active CPAP + Motivational Enhancement | 40 | 45.6 | ± 12.1 | 52.0 | 20.9 | 55.9 | 1 | 41 |
Treatment arm vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 138 | 48.7 | ± 10.0 | 55.9 | 13.1 | 55.9 | 31 | 169 |
Conservative Medical Therapy (CMT) | 37 | 47.8 | ± 10.5 | 52.0 | 20.9 | 55.9 | 7 | 44 |
CMT + Sham CPAP | 33 | 49.5 | ± 9.6 | 55.9 | 28.7 | 55.9 | 9 | 42 |
CMT + Active CPAP | 35 | 50.1 | ± 8.2 | 55.9 | 28.7 | 55.9 | 7 | 42 |
CMT + Active CPAP + Motivational Enhancement | 33 | 47.4 | ± 11.5 | 55.9 | 13.1 | 55.9 | 8 | 41 |
Treatment arm vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Month-12 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 77 | 48.4 | ± 11.2 | 55.9 | 13.1 | 55.9 | 31 | 108 |
Conservative Medical Therapy (CMT) | 21 | 49.4 | ± 10.0 | 55.9 | 24.8 | 55.9 | 8 | 29 |
CMT + Sham CPAP | 20 | 48.1 | ± 13.0 | 55.9 | 17.0 | 55.9 | 7 | 27 |
CMT + Active CPAP | 17 | 49.7 | ± 9.3 | 55.9 | 24.8 | 55.9 | 9 | 26 |
CMT + Active CPAP + Motivational Enhancement | 19 | 46.5 | ± 12.5 | 48.1 | 13.1 | 55.9 | 7 | 26 |
Age at visit vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 46.8 | ± 11.5 | 52.0 | 13.1 | 55.9 | 6 | 169 |
46.0 to 59.0 years | 42 | 46.8 | ± 11.9 | 52.0 | 13.1 | 55.9 | 1 | 43 |
59.0 to 66.0 years | 38 | 48.6 | ± 10.2 | 55.9 | 20.9 | 55.9 | 4 | 42 |
66.0 to 69.0 years | 42 | 44.1 | ± 13.2 | 48.1 | 17.0 | 55.9 | - | 42 |
70.0 to 76.0 years | 41 | 47.8 | ± 10.0 | 52.0 | 20.9 | 55.9 | 1 | 42 |
Age at visit vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 138 | 48.7 | ± 10.0 | 55.9 | 13.1 | 55.9 | 31 | 169 |
46.0 to 60.0 years | 29 | 45.4 | ± 12.5 | 52.0 | 13.1 | 55.9 | 14 | 43 |
60.0 to 66.0 years | 34 | 48.1 | ± 10.5 | 55.9 | 24.8 | 55.9 | 8 | 42 |
66.0 to 70.0 years | 39 | 50.3 | ± 8.8 | 55.9 | 20.9 | 55.9 | 3 | 42 |
70.0 to 77.0 years | 36 | 50.2 | ± 8.0 | 55.9 | 32.6 | 55.9 | 6 | 42 |
Age at visit vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Month-12 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 77 | 48.4 | ± 11.2 | 55.9 | 13.1 | 55.9 | 31 | 108 |
47.0 to 60.0 years | 14 | 44.5 | ± 14.3 | 50.0 | 17.0 | 55.9 | 13 | 27 |
60.0 to 66.0 years | 21 | 48.1 | ± 9.4 | 48.1 | 24.8 | 55.9 | 6 | 27 |
66.0 to 70.0 years | 21 | 48.7 | ± 12.3 | 55.9 | 13.1 | 55.9 | 6 | 27 |
71.0 to 77.0 years | 21 | 51.1 | ± 9.4 | 55.9 | 20.9 | 55.9 | 6 | 27 |
Gender vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 46.8 | ± 11.5 | 52.0 | 13.1 | 55.9 | 6 | 169 |
Male | 107 | 48.4 | ± 10.3 | 55.9 | 20.9 | 55.9 | 3 | 110 |
Female | 56 | 43.8 | ± 13.1 | 48.1 | 13.1 | 55.9 | 3 | 59 |
Gender vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 138 | 48.7 | ± 10.0 | 55.9 | 13.1 | 55.9 | 31 | 169 |
Male | 94 | 49.7 | ± 9.4 | 55.9 | 13.1 | 55.9 | 16 | 110 |
Female | 44 | 46.6 | ± 10.9 | 52.0 | 20.9 | 55.9 | 15 | 59 |
Gender vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Month-12 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 77 | 48.4 | ± 11.2 | 55.9 | 13.1 | 55.9 | 31 | 108 |
Male | 51 | 50.2 | ± 9.7 | 55.9 | 17.0 | 55.9 | 21 | 72 |
Female | 26 | 44.8 | ± 13.2 | 48.1 | 13.1 | 55.9 | 10 | 36 |
Race vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Baseline Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 162 | 46.9 | ± 11.5 | 52.0 | 13.1 | 55.9 | 6 | 168 |
White | 147 | 46.7 | ± 11.6 | 52.0 | 13.1 | 55.9 | 5 | 152 |
American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
Black or African American | 10 | 46.5 | ± 11.9 | 53.9 | 24.8 | 55.9 | 1 | 11 |
Asian | 4 | 53.0 | ± 5.8 | 55.9 | 44.2 | 55.9 | - | 4 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
Other | 1 | 44.2 | - | 44.2 | 44.2 | 44.2 | - | 1 |
Multiple | - | - | - | - | - | - | - | - |
Race vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Month-6 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 137 | 48.8 | ± 10.0 | 55.9 | 13.1 | 55.9 | 31 | 168 |
White | 128 | 48.9 | ± 9.8 | 55.9 | 13.1 | 55.9 | 24 | 152 |
American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
Black or African American | 6 | 50.7 | ± 12.7 | 55.9 | 24.8 | 55.9 | 5 | 11 |
Asian | 3 | 40.3 | ± 13.5 | 32.6 | 32.6 | 55.9 | 1 | 4 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
Other | - | - | - | - | - | - | 1 | 1 |
Multiple | - | - | - | - | - | - | - | - |
Race vs Medical Outcomes Study SF-36: Role limitations due to emotional problem subscale normal score
Month-12 Follow-up Visit
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 77 | 48.4 | ± 11.2 | 55.9 | 13.1 | 55.9 | 31 | 108 |
White | 71 | 48.7 | ± 10.7 | 55.9 | 13.1 | 55.9 | 24 | 95 |
American Indian or Alaskan Native | - | - | - | - | - | - | - | - |
Black or African American | 5 | 42.7 | ± 18.1 | 55.9 | 20.9 | 55.9 | 4 | 9 |
Asian | 1 | 55.9 | - | 55.9 | 55.9 | 55.9 | 2 | 3 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | - | - |
Other | - | - | - | - | - | - | 1 | 1 |
Multiple | - | - | - | - | - | - | - | - |